IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
IDEAYA Biosciences has raised $345.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
IDEAYA Biosciences's investors include Perceptive Advisors, Canaan Partners, Google Ventures, Biotechnology Value Fund, 5AM Ventures.
IDEAYA Biosciences is headquartered in South San Francisco, United States.
IDEAYA Biosciences is an oncology-focused biotechnology company that develops therapeutics for patients with genetically-defined cancers.
IDEAYA Biosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IDEAYA Biosciences — Funding & Investors." VCBacked, June 8, 2026, https://www.vcbacked.co/company/ideaya-biosciences. Accessed July 19, 2026.
VCBacked. (2026). IDEAYA Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ideaya-biosciences
{{cite web |title=IDEAYA Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/ideaya-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated